Clinical Trial Update: Descartes-11 Consolidation Treatment in Patients With High-Risk Multiple Myeloma Who Have Residual Disease After Induction Therapy [Phase 2]

View source ↗

Summary

This clinical trial update reports Phase 2 results for Descartes-11 used as consolidation therapy in high-risk multiple myeloma patients with residual disease a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Descartes-11

Snippet

Sponsor: Cartesian Therapeutics | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED | Results posted: 2024-12-03